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Skeletal muscle constitutes 40% of the human body mass, and
alterations in muscle mass and strength may result in physical
disability. Therefore, the elucidation of the factors responsible for
muscle force development is of paramount importance. Excitation–
contraction coupling (ECC) is a process during which the skeletal
muscle surface membrane is depolarized, causing a transient re-
lease of calcium from the sarcoplasmic reticulum that activates the
contractile proteins. The ECC machinery is complex, and the func-
tional role of many of its protein components remains elusive. This
study demonstrates that deletion of the gene encoding the sarco-
plasmic reticulum protein JP45 results in decreased muscle strength
in young mice. Specifically, this loss of muscle strength in JP45
knockout mice is caused by decreased functional expression of the
voltage-dependent Ca2 channel Cav1.1, which is the molecule that
couples membrane depolarization and calcium release from the
sarcoplasmic reticulum. These results point to JP45 as one of the
molecules involved in the development or maintenance of skeletal
muscle strength.
calcium release  excitation–contraction coupling
In skeletal muscle excitation–contraction coupling (ECC), anelectrical signal (sarcolemma depolarization) is converted to a
chemical signal (a transient increase in the intracellular calcium
concentration) (1, 2), which ultimately leads to muscle contrac-
tion, a vital human function that is often diminished in the
elderly, impairing their quality of life (3). ECC occurs at the
triad, a structure made up of two membrane compartments
where two interacting macromolecular complexes containing
two distinct Ca2 channels intimately involved in ECC are
located. The voltage-gated Ca2 channel Cav1 is localized in the
transverse (T) tubule membranes, and the ryanodine receptors
(RyR) are the calcium-release channel localized in the SR
terminal cisternae membranes (4–10). The Cav1 is a heterooli-
gomeric complex made up of at least four subunits: Cav1.1, 1a,
2–, and  (11–15). The pore-forming Cav1.1 is an integral
membrane protein and is indispensable for ECC, the cytosolic
1a and 2– subunits have regulatory functions, and the role of
the -subunit has yet to be clearly defined (12, 15, 16). The 1a
subunit associates tightly with Cav1.1 by binding to the -inter-
acting domain (17) and plays a crucial role in plasma membrane
expression of Cav1.1. Targeting of Cav1.1 at the triad results from
the cooperation of a sequence located in the COOH domain of
Cav1.1 (18–20) with other domains/polypeptides. T tubule de-
polarization evokes intramembrane Cav1.1 charge movement
(21), which is transmitted to the RyR to initiate ECC. Contractile
proteins are activated by SR terminal cisternae calcium release
via RyR opening (22).
In addition to the calcium-release channel (RyR), the SR and
T tubule membranes also have a variety of proteins that, because
of their subcellular location, are thought to contribute to ECC
(23, 24). They are involved in (i) calcium storage (calsequestrin)
(25), (ii) signal transduction (triadin TD, junctin JC, mitsugu-
min-29, JP45) (23, 24, 26, 27), (iii) calcium homeostasis (Ca2
pump, Na/Ca exchanger) (28), and (iv) maintenance of SR
spatial organization and integrity (junctophilin) (29). Our pre-
vious studies (24, 30) demonstrated that JP45, an integral protein
constituent of the skeletal muscle SR junctional face membrane,
interacts with Cav1.1 and the luminal calcium-binding protein
calsequestrin (30, 31). Cav1.1 and JP45 form a complex that is
down-regulated during aging and may contribute to decayed
muscle strength and physical disability in the elderly (31, 32). On
the basis of these initial observations, we reasoned that skeletal
muscle strength may depend not only on the composition and
functional integrity of the contractile apparatus but also on the
molecular composition of the ECC machinery. To test this
hypothesis, we created a JP45 knockout (KO) animal model and
examined the functional and biochemical properties of skeletal
muscles from young JP45 KO mice and age-matched wild-type
littermates.
Results and Discussion
Phenotype of the JP45 KO Mice. The absence of JP45 in the skeletal
muscle of the mutant mice was confirmed by Western blot
analysis of SR membranes isolated from JP45 KO and wild-type
mice (Fig. 1D). The ablation of JP45 is not associated with major
alterations in other SR proteins (Fig. 1E). Homozygous JP45 KO
mice did not exhibit either a lethal phenotype or defects in
embryonic or postnatal development. To look for a skeletal
muscle phenotype, we analyzed the animals using a voluntary
running wheel setup. The mice had free access to the wheel at
any time of day. This experimental approach avoids potential
problems linked to the effect of circadian rhythm on animal
activity and/or animal compliance in performing nonvoluntary
motor activity. We assessed spontaneous dark-phase (17.00–
5.00 h) motor activity of 3-month-old wild-type and JP45 KO
mice (Fig. 2). In the first week, the total running distance of the
wild-type mice was approximately double that of the JP45 KO
mice. Two weeks of training improved skeletal muscle perfor-
mance in both groups. After 3 weeks of training, the total
running distance increased 2- to 3-fold until it plateaued at
9–10 kilometers per night for both sets of mice, although the
total running distance remained significantly lower in the JP45
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KO mice (Mann–Whitney test, two-tailed, P  0.05). We also
found that the median cruise speed of the JP45 KO mice was
significantly lower that that of the wild-type mice (Mann–
Whitney test, two-tailed, P  0.05).
Mechanical Properties of Intact Skeletal Muscle from Wild-Type and
JP45 KO Mice. The reduced speed and total running distance
among the JP45 KO mice may be associated with decreased
muscle strength (33) resulting from alterations in their ECC
machinery caused by the lack of JP45. To investigate this
possibility, we studied the mechanical properties of intact
extensor digitorum longus (EDL) and soleus muscles from
wild-type and JP45 KO mice (Fig. 3 A–D). Analysis of muscle
contraction revealed significant differences in JP45 KO mice.
Their EDL and soleus muscles exhibited decreased twitch and
maximal tetanic absolute force compared with wild-type mice,
whereas their contraction and relaxation kinetics did not differ
significantly (Table 1). The reduced absolute force observed in
their skeletal muscles cannot be attributed to loss of contrac-
tile protein content, because the wet weight of their EDL and
soleus muscles did not significantly differ from those of
wild-type mice. The myofibril area in EDL and soleus muscles
also did not differ significantly between JP45 KO and wild-type
mice [supporting information (SI) Fig. 6]. The muscle specific
force (maximal tetanic force normalized to muscle cross-
sectional area) of EDL and soleus muscles from JP45 KO mice
was also significantly impaired. EDL maximal tetani recorded
in JP45 KO (287  38.6 mNmm2, mean  SD, n  22) are
25% lower than those recorded in wild-type mice (381 46.7
mNmm2, n  13, P  0.05). A similar decrease in maximal
tetanic force generation was observed in solei from JP45 KO
(244 41.6, n 22) compared with wild-type (301 46.7, n
13) mice (P  0.05). Specific tetanic force decreased in single,
intact f lexor digitorum brevis (FDB) muscle fibers to an extent
similar to that in EDL and soleus whole-muscle contraction,
but the calcium sensitivity of the contractile proteins, tested in
the same fiber after chemical skinning, did not differ signifi-
cantly in JP45 KO compared with wild-type mice (SI Fig. 7).
The decrease in force output is not due to fast-to-slow fiber
transition because we observed no changes in the expression
of myosin heavy chain (MHC) isoforms in EDL (E) and soleus
(F) muscles. EDL from JP45 KO and wild-type mice expresses
predominantly MHC IIb, whereas soleus expresses mainly
MHC I and IIa. No gross alterations in the overall microscopic
structure were observed in JP45 KO mice (data not shown).
Fig. 1. Generation of JP45 KO mice. (A) Targeting vector construction strategy. (B) Southern blot analysis of genomic DNA from ES cells of mutant mice according
to Nishi et al. (27). (C) PCR analysis of genomic DNA from wild-type and JP45 KO mice. (D) SR R1, R2, and R4 fraction proteins (10 g) separated by SDS/PAGE and
stained with Coomassie BB (Left) and anti-JP45 Ab (Right). (E) Western blot analysis of SR fraction proteins with anti-SR proteins.
Fig. 2. Spontaneous activity of JP45 KO mice. Shown is dark-phase spontaneous activity in 12-week-old wild-type (squares) and JP45 KO (triangles) mice
individually housed in cages equipped with a running wheel. Data points are expressed as mean SEM (n 10–13 mice). P 0.05 (Mann–Whitney two-tailed
test).
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Ablation of JP45 Decreases Cav1.1 Density in Sarcotubular Mem-
branes. Because the decreased muscle strength observed in
JP45 KO mice cannot be explained by loss of contractile
proteins or changes in MHC isoforms, we thought that it might
be linked to alterations of the ECC mechanism. We reasoned
that the site of such alterations might be the supramolecular
complex made up of Cav1.1 and RyR. Cav1.1 is the voltage
sensor, which generates charge movement that is transmitted
to the RyR to initiate the calcium release necessary to activate
muscle contraction. Because JP45 forms a complex with Cav1.1
(30), we investigated whether the decreased muscle function
caused by JP45 ablation was related to alterations in the
expression of Cav1.1. Fig. 4 shows that, indeed, chronic JP45
depletion is accompanied by a decrease in the density of Cav1.1
in the sarcotubular membranes, as indicated by radioligand
binding assays with the high-affinity Cav1.1 probe [3H] PN200-
110 (Fig. 4A). Scatchard analysis of [3H] PN200-110 isothermal
equilibrium binding to isolated sarcotubular membranes from
JP45 KO and wild-type mice shows that the former have a
significant decrease in PN200-110 Bmax with no alteration of its
dissociation constant [Bmax, pmol/mg of protein  5.8  0.40
vs. 7.9  0.30, mean  SD (n  11 for JP45 KO and wild-type,
respectively); Kd  1.3  0.20 vs. 1.1  0.10 nM, mean  SD
(n  11 for JP45 KO and wild-type mice, respectively)]. The
decrease of PN200-110 binding in the sarcotubular membranes
Fig. 3. Mechanical properties of skeletal muscle from wild-type and JP45 KO
mice. (A–D) Shown is twitch (A and B) and maximal tetanus force (C and D)
recorded in wild-type (dotted line) and JP45 KO (continuous line) mice. (E)
SDS/PAGE of MHC from wild-type and JP45 KO mice. (F and G) MHC isoforms
in EDL (F) and soleus (G).
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from JP45 KO mice is not due to differences in recoveries of
T tubules membrane because we did not observe a difference
in the content of the T tubule membrane marker albumin in the
isolated sarcotubular membrane fractions from wild-type and
JP45 KO mice (SI Fig. 8). Semiquantitative RT-PCR with
Cav1.1-specific primers suggests that the decrease in Cav1.1
density is not linked to alterations in Cav1.1 gene transcrip-
tion (Fig. 4B).
Electrophysiological Properties of Skeletal Muscle Fibers from Wild-
Type and JP45 KO Mice. The decreased Cav1.1 membrane density
in the skeletal muscle from JP45 KO mice causes modifications
in the fiber’s electrophysiological properties; in fact, we found a
reduction in the asymmetric capacitive current, which results in
a 40% decrease in maximal Cav1.1 gating charge in intact FDB
fibers (Fig. 4D) without significantly affecting charge movement
half-activation potential (Table 2). These results together with
previous studies on JP45 overexpression (30, 34) indicate that the
stoichiometry of JP45–Cav1.1 subunit exhibited by mature skel-
etal muscle is crucial for maintaining the molecular and func-
tional expression of the Cav1.1 subunit (31).
Because the Cav1.1 charge movement is the activating signal
for RyR1-mediated calcium release from the SR, we performed
experiments to evaluate whether depolarization-induced cal-
cium release from the SR of JP45 KO mice is also affected. We
found that the peak depolarization-induced calcium release is
significantly decreased in JP45 KO fibers (Fig. 5A). The flux
amplitudes JT (Mms1) and JS (Mms1) were 181  13 and
115  18 for fibers from wild-type mice and 108  17 and 68 
7.3 for fibers from JP45 KO mice, respectively (P  0.05). The
decreased depolarization-induced calcium release is apparently
not due to reduced RyR1 calcium-release channel density be-
cause Scatchard analysis of [3H]ryanodine binding to heavy SR
fractions revealed no changes (Bmax values were 11.60  2.0 and
13.51 1.9 pmol/mg of protein for wild-type and JP45 KO mice,
respectively) (Fig. 5B). The lack of significant differences in their
resting calcium concentrations indicates that myoplasmic calci-
um-buffer capacity is preserved in JP45 KO mice (Fig. 5C). A
nonsignificant difference in Ca ATPase activity in the light SR
fraction supports this conclusion (SI Fig. 9).
We also investigated 4-chloro-m-cresol-induced force output
in single, intact FDB fibers to finely assess maximal SR-
releasable calcium (35). We found no differences in force
generation between wild-type and JP45 KO muscle fibers in-
duced by the RyR1 agonist 4-chloro-m-cresol (Fig. 5D). On the
basis of 4-chloro-m-cresol-induced force experiments, we are
confident that the reduction in voltage-dependent calcium re-
lease is not a result of SR calcium-store depletion but rather of
altered Cav1.1expression.
The most important and novel finding of this report is the
demonstration that alterations to the molecular composition of
the ECC machinery resulting from JP45 depletion are sufficient
to induce a 20–30% decrease in skeletal muscle strength in
young animals. In addition, this study elucidates the underlying
molecular mechanism(s) responsible for the decay of muscle
strength in JP45 KO mice. It unambiguously shows that the
decrease in muscle strength is not due to changes in muscle fiber
types or contractile protein properties but to alterations of the
signal transduction machinery between Cav1.1 and RyR1 at
the T tubule/SR junction. We believe that the crucial switch is the
activating calcium signal from the SR, which is then delivered to
the contractile proteins. Altering the components of this switch
may affect global muscle function. This conclusion is supported
by the data demonstrating that reduced membrane depolariza-
tion due to impaired functional expression of Cav1.1 reduces
calcium release. The molecular basis of the reduction in Cav1.1
functional expression is likely linked to protein–protein interac-
tions occurring within the EC-coupling macromolecular com-
plex. Membrane targeting of Cav1.1 depends on amino acid
sequences contained within the COOH terminal domain and in
the I–II loop of the Cav1.1 (20). JP45 interacts with both Cav1.1
domains involved in membrane targeting (31), and the lack of
these interactions may interfere with either proper Cav1.1 mem-
brane targeting or the stabilization of the Cav1.1 complex in the
Fig. 4. Ablation of JP45 reduces Cav1.1 charge movement and membrane
density. (A) Sarcotubular R1 fraction 3H-PN200-110 equilibrium binding. Data
points represent mean SD of 10–14 determinations carried out in three differ-
ent R1 fraction preparations, which contain membrane vesicles deriving from T
tubules (37). SERCA1 expression, used as a marker of light SR membranes (R1) and
a reference for PN200-110 binding, did not differ significantly in JP45 KO and
wild-type mouse muscles. (B) Semiquantitative RT-PCR. The figure represents
three experiments with RNA extracted from two different hind limb muscle
preparations. (C) Sarcotubular membrane proteins (15 g) were separated by
SDS/PAGE and stained with affinity-purified anti-Cav1.1. (D Upper) Charge-
movement vs. membrane voltage (Vm) relationship recorded in FDB fibers from
wild-type (n 15) and JP45 KO (n 16) mice. Data points, expressed as mean
SEM, were fitted to a Boltzmann equation. Best-fitting parameters are shown in
Table 2. (D Lower) Illustrative charge-movement recordings. Membrane poten-
tial is shown on the right. Dotted lines represent the baseline.
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T tubular membrane. In conclusion, this study provides new
insights into some mechanism(s) responsible for diminished
muscle strength.
Experimental Procedures
Generation of JP45 KO Mice. JP45 KO mice were generated as
previously described (27). A mouse genomic library (from
Stratagene) was screened with a cDNA probe to isolate genomic
clones encompassing the 5 end of the JP45 gene. A targeting
vector was constructed by using a 5-end JP45 genomic clone,
Neo-resistance, and the diphtheria toxin gene DT-A as positive-
selection and negative-selection cassettes, respectively (Fig. 1A).
A SalI-linearized vector was used to transfect J1 mouse ES cells,
and 140 ES clones carrying a homologous recombination were
identified by Southern blot screening (Fig. 1B). JP45/ mice
were backcrossed three times in a C57BL6 background and then
intercrossed to obtain JP45/ mice. Genotyping was carried out
by PCR using the following primers: JP45F2, 5-TAA AGA
CAG AGA CCA CAT CCT CCC-3; JP45R4, 5-GAC AAG
GGG TGT GGG GTA TGA GGC-3 (Fig. 1C).
DNA and RNA Manipulation. Nucleic acid manipulation was carried
out as previously described (27, 36).
Microsomal Preparation and Biochemical Analysis. The isolation of
SR membrane fractions (37), SDS/PAGE, and Western blot
analysis were carried out as described by Anderson et al. (30).
[3H] PN200-110 and [3H]ryanodine binding was carried out
according to Anderson et al. (38). Curve fitting was performed
by using Prism4 software (GraphPad). MHC band separation
was performed as described by Talmadge and Roy (39), and
densitometry was analyzed with the NIH ImageJ1.36 software.
In Vivo and in Vitro Muscle Strength Assessment. Animals were
individually housed in cages equipped with a running wheel
carrying a magnet. Wheel revolutions were registered by a reed
sensor connected to an I-7053D Digital-Input module (Spectra),
and the revolution counters were read by a standard laptop
computer via an I-7520 RS-485-to-RS-232 interface converter
(Spectra). Digitized signals were processed by the ‘‘mouse
running’’ software developed at Santhera Pharmaceuticals. To
test force in vitro, EDL and soleus muscles were dissected and
mounted into a muscle testing setup (Heidelberg Scientific
Instruments). Muscle force was digitized at 4 kHz by using an AD
Instruments converter and stimulated with 15-V pulses for 0.5
ms. EDL tetanus was recorded in response to 400-ms pulses at
10–120 Hz, whereas, for soleus, 1,100-ms pulses at 10–150 Hz
were applied. Specific force was normalized to the muscle
cross-sectional area [CSAwet weight (mg)/length (mm) 1.06
(density mg/mm3)] (40).
Cell Electrophysiology and Optical Recordings. FDB fibers from
wild-type and JP45 KO were enzymatically dissociated, plated,
and recorded as previously described (41). For whole-cell patch
clamp, the composition of the pipette solution was 140 mM
Cs-aspartate, 5 mM Mg-aspartate2, 10 mM Cs2EGTA [ethylene
glycol-bis(-aminoethyl ether)-N,N,NN-tetraacetic acid], and
10 mM Hepes [N-(2-hydroxyethyl)piperazine-N-(2-ethanesul-
fonic acid)]. The pH was adjusted to 7.4 with CsOH. The external
solution contained 145 mM tetraethylammonium hydroxide
(TEA)Cl, 10 mM CaCl2, 10 mM Hepes, and 0.001 mM tetro-
dotoxin. Solution pH was adjusted to 7.4 with TEAOH.
For charge-movement recording, calcium current was blocked
by adding 0.5 Cd2 plus 0.3 La3 to the external solution (8, 32).
We recorded the charge movement corresponding to gating of
the Cav1.1 channel. To this end, we used a protocol consisting of
a 2-s prepulse to 30 mV and a subsequent 5-ms repolarization
Table 2. Best-fitting parameters describing the voltage dependence of charge movement and intracellular Ca2
release in FDB fibers from wild-type and JP45 KO mice
Mice
Charge movement* Intracellular Ca2 release†
Qmax, C/F V1/2Q, mV K 	F/Fmax V1/2F, mV K
Wild type 30.5  3.4 7.6  0.92 14.2  1.8 17.8  2.6‡ 6.4  0.75 12.0  1.5
JP45 KO 0.61  0.08 12.9  0.19 15.4  1.8 0.39  0.06‡ 13.0  0.15 16.3  1.9
Values are mean  SEM. ‡, P  0.01 (statistically significant differences between wild type and JP45 KO).
*n  15 (wild type) and 16 (JP45 KO) fibers.
†n  17 (wild type) and 20 (JP45 KO) fibers.
Fig. 5. Ablation of JP45 reduced maximal voltage-dependent SR Ca2
release. (A Upper) SR Ca2 release in FDB fibers from wild-type (n  17) and
JP45 KO (n 20) mice. Data points (mean SEM) were fitted to a Boltzmann
equation. (A Lower) OGB-5N transients in FDB fibers from wild-type and JP45
KO mice in response to various command pulses corresponding to the steepest
part of the fluorescence/membrane voltage relationship. (B) [3H]Ryanodine
binding to heavy SR fractions from wild-type and JP45 KO mice. Points
represent the mean  SD of five to eight determinations in two different R4
fraction preparations. (C) Fura-2 resting Ca2 concentration measurements in
FDB fibers from wild-type (n  72 fibers) and JP45 KO (n  71) mice did not
differ significantly. (DUpper) Typical contractures in response to 1 mM 4-CmC
in FDB fibers from wild-type (n  8) and JP45 KO (n  11) mice. (D Lower)
Differences are not statistically significant.
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to a pedestal potential of 50 mV followed by a 25-ms depo-
larization from 50 mV to 50 mV with 10-mV intervals (8, 31).
Intramembrane charge movements were calculated as the inte-
gral of the current in response to depolarizing pulses and are
expressed per membrane capacitance (coulombs per farad). For
analysis of the relationship between charge movement and
membrane voltage, data points were fitted to a Boltzmann
equation of the form QonQmax/[1 exp(VQ1/2 Vm)/K], where
Qmax is the maximum charge, Vm is the membrane potential,
VQ1/2 is the charge movement half-activation potential, and K is
the steepness of the curve. The best-fitting parameters are
included in Table 1. For intracellular Ca2 recording, the
fiber-holding potential was 80 mV, and the duration of the
command pulses was 40 ms to better display the steady compo-
nent of the SR release function. The pipette solution contained
20 mM Cs2EGTA and 500 M Oregon Green Bapta (OGB)-5N
(Invitrogen). OGB-5N transients were recorded by using a laser
scanning confocal microscope (Radiance 2100; Bio-Rad/Zeiss)
in linescan mode. Images were converted into fluorescence
intensity. SR Ca2 release flux was calculated by using a
single-compartment model as described (42). The software for
these calculations was kindly provided by J. Vergara (University
of California, Los Angeles). Resting Ca2 concentration was
measured by using fura-2AM as the Ca2 probe in enzymatically
dissociated FDB fibers. Ratios of the fluorescence recorded at
380- and 340-nm excitation wavelengths were converted into
Ca2 concentration following published procedures (43). Force
recordings in single, intact FDB muscle fibers were as previously
described (44, 45).
Statistical Analysis. Statistical analysis was performed by using
Student’s unpaired t test and the Mann–Whitney U test when
values were not normally distributed. P  0.05 was considered
significant.
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